Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.0%

25 terminated/withdrawn out of 279 trials

Success Rate

81.6%

-4.9% vs industry average

Late-Stage Pipeline

4%

11 trials in Phase 3/4

Results Transparency

2%

2 of 111 completed trials have results

Key Signals

80 recruiting2 with results15 terminated10 withdrawn

Enrollment Performance

Analytics

N/A
121(68.8%)
Phase 2
26(14.8%)
Phase 1
17(9.7%)
Phase 3
7(4.0%)
Phase 4
4(2.3%)
Early Phase 1
1(0.6%)
176Total
N/A(121)
Phase 2(26)
Phase 1(17)
Phase 3(7)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (279)

Showing 20 of 279 trials
NCT06961578Not ApplicableRecruiting

SCORE Study: Comparing Surgery and Rigid Collar Treatment for Odontoid Fractures in Adults Over 70

Role: collaborator

NCT04923958Not ApplicableRecruiting

Rapid Research in Diagnostics Development for TB Network

Role: collaborator

NCT04084431Not ApplicableWithdrawn

Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases

Role: lead

NCT05871307Not ApplicableRecruiting

Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases

Role: lead

NCT03838419Not ApplicableSuspended

Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer

Role: lead

NCT06931938Not ApplicableRecruiting

Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia

Role: collaborator

NCT05946772Phase 2Recruiting

Cyclosporine In Takotsubo Syndrome

Role: lead

NCT05525325Not ApplicableRecruiting

Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke

Role: lead

NCT04613388Recruiting

Registry Study of Proton Radiotherapy in Lymphoma

Role: lead

NCT04607096Not ApplicableRecruiting

Intermittent Fasting to Improve Insulin Secretion

Role: collaborator

NCT04925583Phase 1Active Not Recruiting

Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location

Role: lead

NCT07420374Not ApplicableRecruiting

Ambulatory Stroke Unit Treatment for Elderly Patients

Role: lead

NCT04185974Not ApplicableRecruiting

Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer

Role: lead

NCT04359238Not ApplicableCompleted

activeDCM - Interventional Clinical Trial of Individualized Activity and Exercise Programs to Improve Outcome in Dilated Cardiomyopathy Guided by Longitudinal Biosensing With Apple Watch

Role: lead

NCT07478042Not ApplicableCompleted

Guiding Catheters in Endovascular Stroke Therapy - Are Balloon Guided Catheters Superior?

Role: lead

NCT04194268Not ApplicableCompleted

Pancreatic Cancer and Carbon Ion Radiotherapy

Role: lead

NCT05027711Phase 2Recruiting

Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases

Role: lead

NCT04845503Not ApplicableActive Not Recruiting

Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer

Role: lead

NCT06954623Not ApplicableRecruiting

Partial Breast Re-irradiation for Breast Cancer

Role: lead

NCT06408116Phase 2Recruiting

Predicting Esophageal Cancer Borders Using PET-Imaging

Role: lead